April 7, 2020 Breast DCIS

Clinical Trial Information

SCHEMA

PROTOCOL: Alliance-AFT-25 COMET

Please Note: Below is a brief description of eligibility, please contact GHCI Research Department to discuss full eligibility requirements.

ELIGIBILITY:

  1. New diagnosis of DCIS without invasive cancer.
  2.  Unilateral, bilateral, unifocal or multifocal DCIS will be eligible, providing that all DCIS meets eligibility.
  3.  No prior history of breast cancer (DCIS or invasive cancer) in either breast.
  4.  At least age 40 at the time of diagnosis.
  5.  Must be female.
  6.  ECOG performance status 0-1.
  7.  No contraindication for surgery.
  8.  Pathologic diagnosis of DCIS within 90 days of registration.
  9.  Grade I/II or ADH/borderline DCIS.
  10.  ER+ and/or PR+.
  11.  HER2 0, 1+, 2+ by IHC, if testing is performed.
  12.  Absence of comedonecrosis.
  13.  Must not have concurrent invasive breast cancer.
  14.  Must not have mass on exam on imaging at site of DCIS prior to biopsy yielding diagnosis.
  15.  Must not have use of investigational cancer agents within 6 weeks prior to diagnosis.

Genesys Hurley Cancer Institute

302 Kensington Avenue
Flint, MI 48503

810-762-8226 | 888-762-8675

Ascension Genesys Hospital
Hurley Medical Center
Michigan Cancer Consortium

Newsletter

Ⓒ 2020 Genesys Hurley Cancer Institute | All Rights Reserved.